About DeVoro Medical
DeVoro Medical is a company based in Fremont (United States) founded in 2018 by Michael P Wallace was acquired by Boston Scientific in September 2021. DeVoro Medical has raised $18 million across 1 funding round from investors including Boston Scientific. DeVoro Medical offers products and services including WOLF Thrombectomy Platform, EkoSonic Endovascular System, and AngioJet Thrombectomy System. DeVoro Medical operates in a competitive market with competitors including Tactile Medical, Intervene, enVVeno Medical, Sky Medical Technology and Veniti, among others.
- Headquarter Fremont, United States
- Founders Michael P Wallace
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Boston Scientific Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$18 M (USD)
in 1 rounds
-
Latest Funding Round
$18 M (USD), Series B
Jul 02, 2020
- Investors
-
Employee Count
Not available
-
Acquired by
Boston Scientific
(Sep 21, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DeVoro Medical
DeVoro Medical offers a comprehensive portfolio of products and services, including WOLF Thrombectomy Platform, EkoSonic Endovascular System, and AngioJet Thrombectomy System.
Removes blood clots in arterial and venous systems
Treats thromboemboli with ultrasound technology
Clears clots in blood vessels efficiently
People of DeVoro Medical
Unlock access to complete
Unlock access to complete
Software Development Team
298 people
Leadership Team
132 people
Senior Team
105 people
Sales and Marketing
103 people
Product Management Team
65 people
Human Resources and Administration
40 people
Principal Team
37 people
Clinical Team
27 people
Unlock access to complete
Funding Insights of DeVoro Medical
DeVoro Medical has successfully raised a total of $18M through 1 strategic funding round. The most recent funding activity was a Series B round of $18 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in DeVoro Medical
DeVoro Medical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Boston Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Wide range of medical devices
|
Locked | Locked | Locked |
Investor details for DeVoro Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DeVoro Medical
Investment portfolio details for DeVoro Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DeVoro Medical
Detailed financials for DeVoro Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Devoro Medical Comparisons
Peer comparison for DeVoro Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DeVoro Medical
DeVoro Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tactile Medical, Intervene, enVVeno Medical, Sky Medical Technology and Veniti, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Home therapy devices for lymphedema and venous ulcers are provided.
|
|
| Locked | Locked | Locked |
Catheter-based therapy for chronic venous insufficiency is developed.
|
|
| Locked | Locked | Locked |
Developer of medical device for the the treatment of venous diseases
|
|
| Locked | Locked | Locked |
Electro-stimulation devices are manufactured for deep vein thrombosis treatment.
|
|
| Locked | Locked | Locked |
A self-expanding stent system for chronic venous disease is developed.
|
Detailed competitors of DeVoro Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Devoro Medical
Complete news archive for DeVoro Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DeVoro Medical
DeVoro Medical was founded in 2018 and raised its 1st funding round 2 years after it was founded.
DeVoro Medical is headquartered in Fremont, United States. It is registered at Fremont, California, United States.
Michael P Wallace is the current CEO of DeVoro Medical. They have also founded this company.
DeVoro Medical is a funded company, having raised a total of $18M across 1 funding round to date.
DeVoro Medical was founded in 2018 and is located in Fremont, United States. Medical devices targeted at cardiac disease treatment are developed by the company within the healthcare sector. Operations center on smart products for the peripheral thrombectomy area, utilizing a novel flow restoration technology. Blood flow in affected body regions is restored through these devices, supporting clinical interventions in cardiovascular care.
DeVoro Medical's top competitors include Tactile Medical, Intervene and enVVeno Medical.
DeVoro Medical offers WOLF Thrombectomy Platform, EkoSonic Endovascular System, and AngioJet Thrombectomy System.
DeVoro Medical has 1 investor. Key investors include Boston Scientific.